Early Days For Discovery Collaborations With Academia In China - China Healthcare Investment Conference
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Big Pharma and device companies are looking to test different models to harness a new source of novel technology as China's innovative life science sectors become more developed. Returnees, Chinese researchers and entrepreneurs that study or work in the West before establishing or working for companies in China, may have a large impact on how Western firms approach partnering in China